The respected investor legal counsel ROSEN encourages BioMarin Pharmaceutical Inc. investors to obtain legal counsel before the important deadline for the securities class action on December 22-BMRN – QNT Press Release

[ad_1]

New York, December 5, 2021 /PRNewswire/ –

why: Rosen Law Firm, a global investor rights law firm, reminds buyers to pay attention to BioMarin Pharmaceutical Inc. (NASDAQ stock code:BMRN) Between January 13, 2020 with September 3, 2021, Including (“class hours”), important December 22, 2021 Deadline for Lead Plaintiff.

so what: If you purchased BioMarin securities during the class action, you may be entitled to compensation through contingency fee arrangements without paying any out-of-pocket expenses or costs.

What to do next: To join the BioMarin class action, please visit http://www.rosenlegal.com/cases-register-2185.html Or call Philip King, Esq. Toll free 866-767-3653 or email pkim@rosenlegal.com or case@rosenlegal.com Information about class actions. …

The full story can be found on Benzinga.com

[ad_2]

Source link